Skip to main content
Equibles
IMUX logo

IMUX · Immunic, Inc. · Webcasts, Transcripts & Audio

Track IMUX — free

Use IMUX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMUX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.84 -0.23 (-2.85%)
Rebalance outlook locked
Market Cap
$127.51M
Shares
13.64M
Volume · Oct 6 164.78K Avg daily vol (3M) 269.59K

Immunic, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Immunic, Inc. (IMUX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q2
2026-08-11
Immunic, Inc. (IMUX) Q2 2026 Earnings Call
Diluted EPS
$-0.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Immunic, Inc. (IMUX) Q1 2026 Earnings Call
Diluted EPS
$-1.08
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-11-07
Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript
Confident tone Vidofludimus calcium lead asset in MS Phase 2 CALLIPER trial in progressive MS Post COVID Syndrome / RAPID_REVIVE trial
Diluted EPS
$-2.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Immunic, Inc. (IMUX) Q2 2024 Earnings Call
Diluted EPS
$-2.10
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Immunic, Inc. (IMUX) Q1 2024 Earnings Call Transcript
Confident tone Vidofludimus calcium in multiple sclerosis Neurofilament light chain (NfL) biomarker Neuroprotective mechanism / Nurr1
Diluted EPS
$-3.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript
Confident tone Vidofludimus calcium in progressive MS (CALLIPER) Vidofludimus calcium in relapsing MS (ENSURE Phase III) IMU-856 in celiac disease
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Immunic, Inc. (IMUX) Q3 2023 Earnings Call Transcript
Diluted EPS
$-5.10
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Immunic, Inc. (IMUX) Q2 2023 Earnings Call Transcript
Diluted EPS
$-5.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Immunic, Inc. (IMUX) Q1 2023 Earnings Call Transcript
Diluted EPS
$-5.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Immunic, Inc. (IMUX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Immunic, Inc. (IMUX) Q3 2022 Earnings Call Transcript
Diluted EPS
$-6.90
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Immunic, Inc. (IMUX) Q2 2022 Earnings Call Transcript
Diluted EPS
$-7.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Immunic, Inc. (IMUX) Q1 2022 Earnings Call Transcript
Diluted EPS
$-7.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Immunic, Inc. (IMUX) Q4 2021 Earnings Call Transcript
Diluted EPS
$-8.10
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Immunic, Inc. (IMUX) Q3 2021 Earnings Call Transcript
Diluted EPS
$-7.60
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Immunic, Inc. (IMUX) Q2 2020 Earnings Call Transcript
Diluted EPS
$-9.00
Audio Transcript Slides 8-K10-Q
Showing 1–16 of 16 webcasts
Key facts CIK 1280776 CUSIP 4525EP200 13F (30d) 1 filings 1 filers Visit website Investor relations